EUVIMEDDescobrir EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Histiocytosis development and clinical variation through the lens of genomics

Paul G Kemps iD, Astrid Gs van Halteren iD, Tom van Wezel iD, Pancras Cw Hogendoorn iD

The Journal of Pathology · 2026-09 · 270 (1) · 23-39

DOI: 10.1002/path.70081 ↗

At a glance

Übersichtsarbeit in The Journal of Pathology, published online on 2026-05-27. Written by Paul G Kemps and 3 co-authors. Institution: Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. Major MEDLINE topics: Genomics, Histiocytosis. 255 references. The full text is freely available (open access, CC BY 4.0). Funded by: Leiden University Medical Center, Histiocytosis Association, Histiocytosis UK.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Histiocytic neoplasms are rare haematologic diseases characterised by clonal expansions of cells with a monocyte, macrophage or dendritic cell phenotype. Their clinical manifestations are diverse, ranging from indolent lesions to aggressive systemic disease. Over recent decades, advances in genomic profiling have transformed the biological understanding of these conditions. The discovery of recurrent oncogenic mutations has reframed histiocytoses from primary inflammatory disorders to myeloid neoplasms, with a notable dependence on aberrant mitogen‐activated protein kinase (MAPK) signalling. Novel genetic drivers continue to be uncovered, with many alterations correlating with distinct clinical and pathological phenotypes. Parallel studies have refined the understanding of disease ontogeny, demonstrating that diverse histiocytoses originate from haematopoietic stem/progenitor cells. In Langerhans cell histiocytosis, the differentiation stage of the mutated precursor cell is considered an important — but not the sole — determinant of disease extent and severity. Additional evidence suggests that specific clinical manifestations, such as neurodegenerative disease, may result from somatic mosaicism affecting tissue‐resident macrophages derived from yolk sac progenitors. Collectively, these findings refine histiocytosis diagnosis, risk stratification, disease monitoring and treatment, with robust activity of kinase inhibitors in patients with severe or refractory disease. In this review, we synthesise recent genomic insights into histiocytosis development and variation, while addressing remaining questions and future directions. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

GenomicsHistiocytosisHumansGenetic Predisposition to DiseaseAnimalsMutationPhenotypeHistiocytosis, Langerhans-Cell

Author keywords

bone neoplasmshematologic diseaseshistiocytosisleukemialymphomamononuclear phagocyte systemmyeloid cellsprotein kinasessequence analysissoft tissue neoplasms

Authors and institutions

  • Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Internal Medicine, Section Allergology & Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Pathology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.

ORCID profiles: Paul G Kemps, Astrid Gs van Halteren, Tom van Wezel, Pancras Cw Hogendoorn

Funding

  • Leiden University Medical Center
  • Histiocytosis Association
  • Histiocytosis UK
  • Stichting Histiocytose Nederland
  • Stichting 1000 Kaarsjes voor Juultje
  • Stichting Kiwanis Run-for-LCH
  • Stichting de Merel
  • Leids Universitair Medisch Centrum

Cite

APA

Kemps, P. G., van Halteren, A. G., van Wezel, T., & Hogendoorn, P. C. (2026). Histiocytosis development and clinical variation through the lens of genomics. The Journal of Pathology, 270(1), 23-39. https://doi.org/10.1002/path.70081

Vancouver

Kemps PG, van Halteren AG, van Wezel T, Hogendoorn PC. Histiocytosis development and clinical variation through the lens of genomics. The Journal of Pathology. 2026;270(1):23-39. doi:10.1002/path.70081

BibTeX
@article{Kemps2026,
  author = {Kemps, Paul G and van Halteren, Astrid Gs and van Wezel, Tom and Hogendoorn, Pancras Cw},
  title = {Histiocytosis development and clinical variation through the lens of genomics},
  journal = {The Journal of Pathology},
  year = {2026},
  volume = {270},
  number = {1},
  pages = {23--39},
  doi = {10.1002/path.70081}
}
Start for free →